Overview

A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients

Status:
Not yet recruiting

Trial end date:
2026-03-15

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics and efficacy of APG-5918 in Healthy Subjects or Anemic Patients.

Phase:

Phase 1

Details

Lead Sponsor:

Ascentage Pharma Group Inc.